BlackRock’s Fennec Pharmaceuticals FENC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.2M Sell
1,226,437
-23,851
-2% -$198K ﹤0.01% 3356
2025
Q1
$7.61M Buy
1,250,288
+23,956
+2% +$146K ﹤0.01% 3421
2024
Q4
$7.75M Sell
1,226,332
-3,145
-0.3% -$19.9K ﹤0.01% 3501
2024
Q3
$6.15M Buy
1,229,477
+42,235
+4% +$211K ﹤0.01% 3576
2024
Q2
$7.25M Buy
1,187,242
+259,776
+28% +$1.59M ﹤0.01% 3500
2024
Q1
$10.3M Sell
927,466
-7,125
-0.8% -$79.2K ﹤0.01% 3282
2023
Q4
$10.5M Buy
934,591
+89,550
+11% +$1M ﹤0.01% 3305
2023
Q3
$6.35M Buy
845,041
+14,922
+2% +$112K ﹤0.01% 3516
2023
Q2
$7.33M Buy
830,119
+778,481
+1,508% +$6.87M ﹤0.01% 3489
2023
Q1
$430K Buy
51,638
+1,094
+2% +$9.1K ﹤0.01% 4481
2022
Q4
$485K Buy
50,544
+1,177
+2% +$11.3K ﹤0.01% 4528
2022
Q3
$399K Sell
49,367
-2,002
-4% -$16.2K ﹤0.01% 4701
2022
Q2
$287K Sell
51,369
-3,970
-7% -$22.2K ﹤0.01% 4850
2022
Q1
$310K Sell
55,339
-2,160
-4% -$12.1K ﹤0.01% 4915
2021
Q4
$253K Buy
57,499
+178
+0.3% +$783 ﹤0.01% 4982
2021
Q3
$541K Sell
57,321
-5,166
-8% -$48.8K ﹤0.01% 4672
2021
Q2
$455K Sell
62,487
-1,070,282
-94% -$7.79M ﹤0.01% 4645
2021
Q1
$7.04M Buy
1,132,769
+25,565
+2% +$159K ﹤0.01% 3720
2020
Q4
$8.25M Buy
1,107,204
+32,171
+3% +$240K ﹤0.01% 3401
2020
Q3
$6.51M Buy
1,075,033
+5,772
+0.5% +$35K ﹤0.01% 3370
2020
Q2
$8.93M Buy
1,069,261
+1,035,798
+3,095% +$8.65M ﹤0.01% 3185
2020
Q1
$199K Sell
33,463
-1,147
-3% -$6.82K ﹤0.01% 4154
2019
Q4
$224K Sell
34,610
-362
-1% -$2.34K ﹤0.01% 4241
2019
Q3
$168K Sell
34,972
-1,316
-4% -$6.32K ﹤0.01% 4297
2019
Q2
$145K Sell
36,288
-503,491
-93% -$2.01M ﹤0.01% 4358
2019
Q1
$2.62M Sell
539,779
-22,437
-4% -$109K ﹤0.01% 3570
2018
Q4
$3.59M Buy
562,216
+2,429
+0.4% +$15.5K ﹤0.01% 3468
2018
Q3
$4.59M Buy
559,787
+4,743
+0.9% +$38.9K ﹤0.01% 3480
2018
Q2
$5.8M Buy
+555,044
New +$5.8M ﹤0.01% 3424